E not available for all women. Furthermore the numbers of women in early menopause were few. These complications of data led us to the crude analysis used in the study. However, our analysis was good enough to show the variability between women, and suggest the need for larger follow-up studies to describe the natural course of menopausal symptoms. To estimate the duration of symptoms among unsele

Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr

Uscript. RL commented the manuscript. PV participated in the designing of the analysis and commented the manuscript. All authors read and approved the final manuscript. Acknowledgement This study was partly financed by Academy of Finland grant 2007?010 (decision number 115088). We thank all women who participated in the trial, the trial staff at clinical centres, and the staff at the National Inst

Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr

And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience

Uscript. RL commented the manuscript. PV participated in the designing of the analysis and commented the manuscript. All authors read and approved the final manuscript. Acknowledgement This study was partly financed by Academy of Finland grant 2007?010 (decision number 115088). We thank all women who participated in the trial, the trial staff at clinical centres, and the staff at the National Inst

Omen with bothersome symptoms first increased and then decreased. Conclusions: There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50?9. Population-based follow-up studies of untreated women would be useful to estimate the symptom burden. Keywords: Menopausal symptoms, Duration, Follow-up, EstoniaBackground A number of stu

Used. With the current knowledge on the mixed effect on diseases, it might be feasible to find a representative cohort of new menopausal women without HT for follow-up studies.8.9.10. 11.Conclusion There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50 -59. Population-based followup studies of untreated women would be usef